Compounds > dn 108
Page last updated: 2024-09-05

dn 108 and thiazoles

dn 108 has been researched along with thiazoles in 3 studies

Compound Research Comparison

Studies
(dn 108)		Trials
(dn 108)		Recent Studies (post-2010)
(dn 108)		Studies
(thiazoles)		Trials
(thiazoles)		Recent Studies (post-2010) (thiazoles)
70133,1792,10012,330

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hayashibe, M; Ino, Y; Kurumi, M; Matsuzaki, Y; Muta, Y; Nomura, Y; Suzuki, S; Ueda, N1
Fukumoto, H; Kanzawa, F; Koh, Y; Koizumi, F; Nakamura, T; Nishio, K; Saijo, N; Tatsumi, Y; Yoshioka, T1
Dirnagl, U; Isaev, N; Karsch, M; Megow, D; Meisel, A; Prass, K; Priller, J; Ruscher, K; Scharff, A1

Other Studies

3 other study(ies) available for dn 108 and thiazoles

ArticleYear
Pharmacological and pharmacokinetic studies of the newly synthesized thiazolidinedione derivative 5-(4-(1-phenyl-1-cyclopropanecarbonylamino)benzyl)-thiazolidine-2 ,4-dio ne.
    Arzneimittel-Forschung, 1998, Volume: 48, Issue:6

    Topics: Aldehyde Reductase; Animals; Blood Glucose; Chromans; Deoxyglucose; Enzyme Inhibitors; Hypoglycemic Agents; Insulin; Male; Mice; Mice, Inbred Strains; Microtubules; Rats; Rats, Sprague-Dawley; Thiazoles; Thiazolidinediones; Triglycerides; Troglitazone

1998
In vitro synergistic interactions between the cisplatin analogue nedaplatin and the DNA topoisomerase I inhibitor irinotecan and the mechanism of this interaction.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2001, Volume: 7, Issue:1

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cell Division; DNA Topoisomerases, Type I; Drug Synergism; Enzyme Inhibitors; Humans; Irinotecan; Lung Neoplasms; Organoplatinum Compounds; Thiazoles; Thiazolidinediones; Topoisomerase I Inhibitors; Tumor Cells, Cultured

2001
Desferrioxamine induces delayed tolerance against cerebral ischemia in vivo and in vitro.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2002, Volume: 22, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Cerebral Cortex; Constriction; Cycloheximide; Deferoxamine; DNA-Binding Proteins; Dose-Response Relationship, Drug; Embryo, Mammalian; Erythropoietin; Gene Expression; Glucose; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Iron Chelating Agents; Ischemic Attack, Transient; Male; Middle Cerebral Artery; Neurons; Nuclear Proteins; Oxygen; Protein Synthesis Inhibitors; Rats; Rats, Wistar; Reperfusion; Thiazoles; Thiazolidinediones; Time Factors; Transcription Factors

2002